96. An Y, Liu J, Zhang G, Ye J, Du Y, Mao Y, Chi C, Tian J (2015) A novel region reconstruction
method for fluorescence molecular tomography. IEEE Trans Biomed Eng 62(7):1818–1826
97. Zhang J, Shi J, Guang H, Zuo S, Liu F, Bai J, Luo J (2016) Iterative correction scheme based
on discrete cosine transform and L1 regularization for fluorescence molecular tomography
with background fluorescence. IEEE Trans Biomed Eng 63(6):1107–1115
98. Pera V, Brooks DH, Niedre M (2016) Multiplexed fluorescence tomography with spectral and
temporal data: demixing with intrinsic regularization. Biomed Opt Express 7(1):111–131
99. Lian L, Deng Y, Xie W, Xu G, Yang X, Zhang Z, Luo Q (2016) High-dynamic-range
fluorescence molecular tomography for imaging of fluorescent targets with large concentration
differences. Opt Express 24(17):19920–19933
100. Zhang G, Liu F, Liu J, Luo J, Xie Y, Bai J, Xing L (2017) Cone beam X-ray luminescence
computed tomography based on bayesian method. IEEE Trans Med Imaging 36(1):225–235
101. Zhou Y, Chen M, Su H, Luo J (2017) Self-prior strategy for organ reconstruction in fluorescence molecular tomography. Biomed Opt Express 8(10):4671–4686
102. Shi J, Udayakumar TS, Wang Z, Dogan N, Pollack A, Yang Y (2017) Optical molecular
imaging-guided radiation therapy part 2: integrated x-ray and fluorescence molecular tomography. Med Phys 44(9):4795–4803
103. Baikejiang R, Zhao Y, Fite BZ, Ferrara KW, Li C (2017) Anatomical image-guided fluorescence molecular tomography reconstruction using kernel method. J Biomed Opt 22(5):055001
104. He X, Wang X, Yi H, Chen Y, Zhang X, Yu J, He X (2017) Laplacian manifold regularization
method for fluorescence molecular tomography. J Biomed Opt 22(4):45009
105. Dutta J, Ahn S, Li C, Cherry SR, Leahy RM (2012) Joint L1 and total variation regularization
for fluorescence molecular tomography. Phys Med Biol 57(6):1459–1476
106. Meng Q, Liu Z, Li F, Ma J, Wang H, Huan Y, Li Z (2015) An HDAC-targeted imaging probe
LBH589-Cy5.5 for tumor detection and therapy evaluation. Mol Pharm 12(7):2469–2476
107. Hu ZY, Yang L, Ning W, Tang C, Meng Q, Zheng J, Dong C, Zhou HB (2018) A high-affinity
subtype-selective fluorescent probe for estrogen receptor β imaging in living cells. Chem
Commun 54(31):3887–3890
108. McCann TE, Kosaka N, Mitsunaga M, Choyke PL, Gildersleeve JC, Kobayashi H (2010)
Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo
near-infrared fluorescence imaging. Bioconjug Chem 21(10):1925–1932
109. Kumar R, Shin WS, Sunwoo K, Kim WY, Koo S, Bhuniya S, Kim JS (2015) Small conjugatebased theranostic agents: an encouraging approach for cancer therapy. Chem Soc Rev 44
(19):6670–6683
110. Lim EK, Kim T, Paik S, Haam S, Huh YM, Lee K (2015) Nanomaterials for theranostics:
recent advances and future challenges. Chem Rev 115(1):327–394
111. Lee MH, Yang Z, Lim CW, Lee YH, Dongbang S, Kang C, Kim JS (2013) Disulfide-cleavagetriggered chemosensors and their biological applications. Chem Rev 113(7):5071–5109
112. Lee MH, Sharma A, Chang MJ, Lee J, Son S, Sessler JL, Kang C, Kim JS (2018) Fluorogenic
reaction-based prodrug conjugates as targeted cancer theranostics. Chem Soc Rev 47(1):28–52
113. Wong PT, Choi SK (2015) Mechanisms of drug release in nanotherapeutic delivery systems.
Chem Rev 115(9):3388–3432
114. Lee MH, Kim JY, Han JH, Bhuniya S, Sessler JL, Kang C, Kim JS (2012) Direct fluorescence
monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended
naphthalimide theranostic prodrug. J Am Chem Soc 134(30):12668–12674
115. Redy-Keisar O, Ferber S, Satchi-Fainaro R, Shabat D (2015) NIR fluorogenic dye as a
modular platform for prodrug assembly: real-time in vivo monitoring of drug release.
ChemMedChem 10(6):999–1007
116. Kumar R, Han J, Lim HJ, Ren WX, Lim JY, Kim JH, Kim JS (2014) Mitochondrial induced
and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and
precise cancer treatment. J Am Chem Soc 136(51):17836–17843
30
J. Tian et al.
method for fluorescence molecular tomography. IEEE Trans Biomed Eng 62(7):1818–1826
97. Zhang J, Shi J, Guang H, Zuo S, Liu F, Bai J, Luo J (2016) Iterative correction scheme based
on discrete cosine transform and L1 regularization for fluorescence molecular tomography
with background fluorescence. IEEE Trans Biomed Eng 63(6):1107–1115
98. Pera V, Brooks DH, Niedre M (2016) Multiplexed fluorescence tomography with spectral and
temporal data: demixing with intrinsic regularization. Biomed Opt Express 7(1):111–131
99. Lian L, Deng Y, Xie W, Xu G, Yang X, Zhang Z, Luo Q (2016) High-dynamic-range
fluorescence molecular tomography for imaging of fluorescent targets with large concentration
differences. Opt Express 24(17):19920–19933
100. Zhang G, Liu F, Liu J, Luo J, Xie Y, Bai J, Xing L (2017) Cone beam X-ray luminescence
computed tomography based on bayesian method. IEEE Trans Med Imaging 36(1):225–235
101. Zhou Y, Chen M, Su H, Luo J (2017) Self-prior strategy for organ reconstruction in fluorescence molecular tomography. Biomed Opt Express 8(10):4671–4686
102. Shi J, Udayakumar TS, Wang Z, Dogan N, Pollack A, Yang Y (2017) Optical molecular
imaging-guided radiation therapy part 2: integrated x-ray and fluorescence molecular tomography. Med Phys 44(9):4795–4803
103. Baikejiang R, Zhao Y, Fite BZ, Ferrara KW, Li C (2017) Anatomical image-guided fluorescence molecular tomography reconstruction using kernel method. J Biomed Opt 22(5):055001
104. He X, Wang X, Yi H, Chen Y, Zhang X, Yu J, He X (2017) Laplacian manifold regularization
method for fluorescence molecular tomography. J Biomed Opt 22(4):45009
105. Dutta J, Ahn S, Li C, Cherry SR, Leahy RM (2012) Joint L1 and total variation regularization
for fluorescence molecular tomography. Phys Med Biol 57(6):1459–1476
106. Meng Q, Liu Z, Li F, Ma J, Wang H, Huan Y, Li Z (2015) An HDAC-targeted imaging probe
LBH589-Cy5.5 for tumor detection and therapy evaluation. Mol Pharm 12(7):2469–2476
107. Hu ZY, Yang L, Ning W, Tang C, Meng Q, Zheng J, Dong C, Zhou HB (2018) A high-affinity
subtype-selective fluorescent probe for estrogen receptor β imaging in living cells. Chem
Commun 54(31):3887–3890
108. McCann TE, Kosaka N, Mitsunaga M, Choyke PL, Gildersleeve JC, Kobayashi H (2010)
Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo
near-infrared fluorescence imaging. Bioconjug Chem 21(10):1925–1932
109. Kumar R, Shin WS, Sunwoo K, Kim WY, Koo S, Bhuniya S, Kim JS (2015) Small conjugatebased theranostic agents: an encouraging approach for cancer therapy. Chem Soc Rev 44
(19):6670–6683
110. Lim EK, Kim T, Paik S, Haam S, Huh YM, Lee K (2015) Nanomaterials for theranostics:
recent advances and future challenges. Chem Rev 115(1):327–394
111. Lee MH, Yang Z, Lim CW, Lee YH, Dongbang S, Kang C, Kim JS (2013) Disulfide-cleavagetriggered chemosensors and their biological applications. Chem Rev 113(7):5071–5109
112. Lee MH, Sharma A, Chang MJ, Lee J, Son S, Sessler JL, Kang C, Kim JS (2018) Fluorogenic
reaction-based prodrug conjugates as targeted cancer theranostics. Chem Soc Rev 47(1):28–52
113. Wong PT, Choi SK (2015) Mechanisms of drug release in nanotherapeutic delivery systems.
Chem Rev 115(9):3388–3432
114. Lee MH, Kim JY, Han JH, Bhuniya S, Sessler JL, Kang C, Kim JS (2012) Direct fluorescence
monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended
naphthalimide theranostic prodrug. J Am Chem Soc 134(30):12668–12674
115. Redy-Keisar O, Ferber S, Satchi-Fainaro R, Shabat D (2015) NIR fluorogenic dye as a
modular platform for prodrug assembly: real-time in vivo monitoring of drug release.
ChemMedChem 10(6):999–1007
116. Kumar R, Han J, Lim HJ, Ren WX, Lim JY, Kim JH, Kim JS (2014) Mitochondrial induced
and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and
precise cancer treatment. J Am Chem Soc 136(51):17836–17843
30
J. Tian et al.